Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include STAT, BioSpace, Endpoints News and finance.yahoo.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 15h ago.
Quick answers
Why is "Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Definium says LSD-based pill reduces anxiety in late-stage study Reuters · 20h ago
- Definium Shares Rise on Successful Psychedelic Drug Trial WSJ · 20h ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Voyage Study of DT120 ODT in Generalized Anxiety Disorder Yahoo Finance · 20h ago
- Definium Therapeutics says its LSD therapy eased anxiety in late-stage trial STAT · 20h ago
- All eyes on psychedelic drugmakers as Definium, Compass near major catalysts BioSpace · 20h ago
- Definium’s LSD drug clears bar in first of two Phase 3 anxiety disorder trials Endpoints News · 20h ago
- DFTX Stock On Track For Worst Day In 9 Months As Investors Brace For Anxiety Trial Data finance.yahoo.com · 20h ago
- Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety Fierce Biotech · 20h ago
Topics
Related trends
Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.